Raia Drogasil SA ADR (RADLY)

Currency in USD
3.25
+0.03(+0.93%)
Closed·

RADLY Financial Summary

Key Ratios

P/E Ratio19.1
Price/Book3.7
Debt / Equity125.94%
Return on Equity19.22%
Dividend Yield1.57%
EBITDA3.06B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of BRL (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.91%
Dividend Yield
1.57%
Industry Median 1.63%
Annualised payout
0.05
Paid unevenly
5-Years Growth
-
Growth Streak

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.60
(+103.08% Upside)

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
0.041 / 0.03
Revenue / Forecast
1.97B / 1.99B
EPS Revisions
Last 90 days

FAQ

What were Raia Drogasil ADR's earnings for the latest quarter?

The Raia Drogasil ADR EPS (TTM) is 0.91. Raia Drogasil ADR reported sales of 10,831.04, net income of 374.00, and EPS of 0.04 for the latest quarter.

What was Raia Drogasil ADR's net income for the latest quarter?

Raia Drogasil ADR's net income for the latest quarter was 374.00.

How did Raia Drogasil ADR's performance compare year-over-year in the latest quarter?

The company's revenue moved from 10,051.01 in the previous quarter to 10,831.04 in the latest quarter, and net income moved from 163.97 to 374.00 compared to the previous quarter.

What is Raia Drogasil ADR's net profit margin on a TTM basis?

Raia Drogasil ADR's trailing twelve months (TTM) net profit margin is 3.08%.

How does Raia Drogasil ADR's debt to equity ratio compare to industry standards?

Raia Drogasil ADR's total debt-to-equity ratio is 125.94%.

What is Raia Drogasil ADR's return on investment on a TTM basis?

Raia Drogasil ADR's trailing twelve months (TTM) return on investment (ROI) is 19.22%.

Did Raia Drogasil ADR gain or lose cash last quarter?

In the latest quarter, Raia Drogasil ADR's net change in cash was 122.64 million.

What were Raia Drogasil ADR's total assets and liabilities in the latest quarter?

As of the latest quarter, Raia Drogasil ADR reported total assets of 23,052.47 million and total liabilities of 9,498.77 million.

How has Raia Drogasil ADR's total revenue grown this year?

Raia Drogasil ADR's total revenue was 10,051.01 in the previous quarter and 10,831.04 in the latest quarter.

What is Raia Drogasil ADR's gross margin on a TTM basis?

Raia Drogasil ADR's trailing twelve months (TTM) gross margin is 29.41%.

What was Raia Drogasil ADR's revenue per share for the latest quarter?

Raia Drogasil ADR's revenue per share for the latest quarter was 105.04.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.